Skip to main content
Ingredients/Tcm/Epimedium Sagittatum

Epimedium Sagittatum.

Strength pending.The research strength is not set yet.

Epimedium Sagittatum supplementation for targeted health support. Icariin inhibits PDE5 (like Viagra, but weaker), may increase nitric oxide, and has bone-protective effects. Traditional use for kidney yang deficiency.

250 to 500mgDaily amount462Studies read

Reviewed March 2026

ESTcm
Epimedium SagittatumIngredientMD
Category
Tcm

What Epimedium Sagittatum is, and what it does.

Does it work
Mild benefits for libido and possibly bone health. Don't believe the hype about dramatic effects.
How much to take
Start with 250 to 500mg a day of an icariin standardised extract, the daily maintenance band. Taken with food, and usually as a course with a break rather than indefinitely.
Time to feel it
Nothing on day one. Anything reported with an icariin standardised extract builds across two to four weeks, and no trial has pinned down a reliable onset.
The first dose
Day one is quiet, maybe a faint warmth. Gut bacteria have to strip the sugars off icariin before much is absorbed, so little lands inside the first 24 hours.
With regular use
Gradual improvements in libido and possibly bone density over months.
How well tolerated
Generally well tolerated. Caution with cardiovascular conditions.
How it feels
Subtle. Maybe slightly warmer, slightly more interested in intimacy.
The overlooked benefit
Icariin only becomes active once gut bacteria strip its sugars off, so two people on the same capsule can end up with quite different amounts circulating.

250 to 500mg a day is where Epimedium Sagittatum works.

How much to take a dayLimited data
250 to 500mg
Daily maintenanceThe everyday amount, and where most daily supplements sit. This is the one you take month after month.
1,000mgClinical territory. Trials run high on purpose, for a set number of weeks, against one measured outcome. Impressive to hit, and not what a daily product is for.
Above 1,500mgPast what the research covers. More capsules rather than more effect.
MORE EFFECT ↑0500mg1,000mg plateauDAILY DOSE →
The shaded band is where the dosing trials landed.

Source: Shindel et al., J Sex Med, 2010; Ma et al., J Ethnopharmacol, 2011

The proof, claim by claim.

These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.

Epimedium Sagittatum has emerging evidence. Based on 462+ studies.

  • Improves sexual functionPDE5 mechanism confirmed, clinical trials show modest effects
  • Bone health supportOsteogenic effects in studies, less human data
  • Works like ViagraSame mechanism but much weaker. Not comparable in effect.
PubMedCochraneClinicalTrials.govNIH ODSSUPP.AI462 studies readLabs test. IngredientMD verifies.PubMedCochraneClinicalTrials.govNIH ODSSUPP.AI462 studies readLabs test. IngredientMD verifies.

Questions people ask about Epimedium Sagittatum.

Does it work like Viagra?
Same mechanism (PDE5 inhibition) but MUCH weaker. Maybe 1/10th the potency. Don't expect the same results.
Why is it called horny goat weed?
Legend says Chinese farmers noticed goats became more sexually active after eating it. Marketing gold.
Which species is best?
Epimedium sagittatum and E. brevicornum are most common. Look for icariin standardization, not species.
Women can take it?
Traditionally used for both sexes. Limited research specifically in women.
Drug interactions?
May interact with blood thinners, blood pressure meds, and nitrates. Similar concerns to PDE5 inhibitors.
Pairs well with19 on file

Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.

Epimedium Sagittatum + L-Citrullinetwo arms of the same cGMP pathway

Icariin slows the breakdown of cGMP by phosphodiesterase-5, while citrulline raises plasma arginine and so the substrate for nitric oxide synthase upstream. One increases cGMP production and the other slows its removal.

Epimedium Sagittatum + L-Arginineprecursor plus downstream signal preservation

Arginine is the direct substrate nitric oxide synthase uses to make nitric oxide, which raises cGMP in vascular smooth muscle. Icariin slows the phosphodiesterase-5 enzyme that clears that cGMP, so the signal persists longer.

Icariin is a prenylated flavonoid glycoside with modest oral absorption and heavy first-pass glucuronidation. Piperine slows intestinal glucuronidation and efflux, raising how much icariin reaches circulation.

Epimedium Sagittatum + probioticsestablished pharmacology

Icariin is a prenylated flavonol glycoside carrying two sugar groups, and it is poorly absorbed in that form. Intestinal bacterial beta-glucosidases strip those sugars to give icariside II and then the icaritin aglycone, which cross membranes far more readily. Individual gut microbial composition therefore shapes how much aglycone a given dose produces, which is established glycoside handling rather than a tested product pairing.

Lactobacillus species carry beta-glucosidase activity capable of deglycosylating dietary flavonoid glycosides. That is the same enzymatic step that converts icariin toward its absorbable aglycone forms. The general enzymology is established; that a specific supplemental strain performs this conversion in the human gut at a meaningful rate is not.

Epimedium Sagittatum + quercetinestablished pharmacology

Quercetin and icariin are both flavonoids cleared substantially by UDP-glucuronosyltransferases and sulfotransferases in the gut wall and liver. Co-dosing them puts two substrates in front of the same conjugating capacity, which can raise exposure to both. Whether this produces a useful effect or simply a pharmacokinetic shift is not established.

Epimedium Sagittatum + zincestablished pharmacology

Zinc is required for the function of numerous enzymes in steroid hormone synthesis and for androgen receptor structure, where it forms the zinc finger domains that bind DNA. Epimedium preparations appear in formulas addressing the same axis. Zinc's role is established biochemistry; the combination itself has no trial behind it.

Epimedium Sagittatum + magnesiumestablished pharmacology

Magnesium is a structural component of bone mineral and a cofactor for the enzymes that activate vitamin D. Icariin has been studied in cell and animal models for effects on osteoblast differentiation markers. The pairing addresses bone mineral handling from a nutrient side and a signalling side.

Epimedium Sagittatum + vitamin-destablished pharmacology

Vitamin D drives intestinal calcium absorption and supports the mineral supply that bone remodelling requires. Icariin's bone-related work sits at the cellular signalling end, in osteoblast and osteoclast marker studies. Supplying the mineral and supporting the signal are distinct contributions.

Epimedium Sagittatum + calciumestablished pharmacology

Calcium is the mineral substrate of the hydroxyapatite that bone is built from, so no signalling input can raise bone mineral content without it. Epimedium preparations are used in bone-support formulas for the signalling side. The combination is substrate plus signal rather than two overlapping actives.

Menaquinone-7 carboxylates osteocalcin, the osteoblast protein that binds calcium into the bone matrix, and matrix Gla protein in vessel walls. That directs where absorbed calcium is deposited. Combined with a calcium and vitamin D base, it completes the mineral-handling picture that epimedium formulas are usually built around.

Epimedium Sagittatum + boronestablished pharmacology

Boron influences the retention of calcium and magnesium and affects the metabolism of steroid hormones, effects measured as marker changes rather than clinical outcomes. It appears in the same formula category as epimedium for both reasons. The mechanistic account is better developed than the outcome record.

Eurycoma longifolia and epimedium are combined routinely in men's botanical formulas, each with its own quassinoid or prenylflavonoid chemistry. Their published work overlaps in the hormonal marker literature without either acting through the other's mechanism. The basis is formulation convention plus separate single-ingredient work, not a combination trial.

Panax ginseng and epimedium are paired in classical Chinese formulas, and both carry glycoside actives that depend on gut microbial deglycosylation to reach their absorbable aglycone forms. Ginsenoside Rb1 becoming compound K is the direct parallel to icariin becoming icaritin. That shared dependence on the microbiome is the most concrete link between them.

Cordyceps and epimedium co-occur in traditional tonic formulas addressing stamina and vitality. Their chemistry is unrelated, nucleoside analogues and polysaccharides on one side, prenylated flavonoids on the other. The pairing rests on formulation tradition rather than on a shared mechanism or a combination study.

Withanolides from ashwagandha have been studied for effects on cortisol and reproductive hormone markers, an axis epimedium formulas also target. The two come from separate herbal traditions but land in the same product category. Combination evidence is absent, so this is complementary positioning rather than a demonstrated interaction.

Epimedium Sagittatum + l-carnitineestablished pharmacology

Carnitine is concentrated in the epididymis and is involved in the energy metabolism of sperm, a distinct route from the nitric oxide and vascular mechanisms epimedium preparations are usually discussed under. The two appear together in male reproductive-support formulas. The rationale is complementary mechanism rather than a tested pair.

Epimedium Sagittatum + mct-oilestablished pharmacology

Prenylation makes icariin and especially its aglycone icaritin markedly more lipophilic than an ordinary flavonol glycoside, and aqueous solubility limits how much dissolves in the gut. A lipid vehicle supports dispersion and micellar uptake. The reasoning is solubility chemistry applied to a known lipophilic active.

Epimedium Sagittatum + vitamin-cestablished pharmacology

Ascorbate regenerates oxidised flavonoid radicals back toward their reduced forms, which is a general feature of the polyphenol and ascorbate relationship rather than something specific to icariin. It also supports collagen hydroxylation in the bone matrix that epimedium formulas concern themselves with. Both points are general biochemistry.

Who should be cautious

Nothing specific on file for Epimedium Sagittatum. Match the label to the daily amount above, and tell your doctor what you take.

Not medical advice. Show the label to your pharmacist.

What Epimedium Sagittatum actually does.

Established

The characteristic constituents of Epimedium are prenylated flavonol glycosides, principally icariin along with epimedin A, B and C. Prenylation makes them considerably more lipophilic than ordinary flavonol glycosides such as rutin.

Established

Icariin is deglycosylated in the gut by bacterial and brush-border beta-glucosidases to icariside II and then to the aglycone icaritin. The aglycones are absorbed far more readily than the parent glycoside, so systemic exposure depends on this conversion rather than on the dose alone.

Established

Absorbed flavonoid aglycones are extensively conjugated by UDP-glucuronosyltransferases and sulfotransferases in the intestinal wall and liver, so most of what circulates is a glucuronide or sulfate rather than the free molecule. This first-pass conjugation is the principal limit on systemic exposure.

Established

Icariin content varies substantially between Epimedium species, between plant parts and with growing conditions and harvest timing, which is why commercial material is standardised to a declared icariin percentage rather than sold by plant weight.

The forms it comes in.

Epimedium herb powderMilled dried leaves and stems of Epimedium sagittatum, carrying the native glycoside profile at whatever concentration the crop produced.Fits Traditional decoction and formulas that want whole-herb material with its full constituent range.Trade-off Icariin content varies widely with species, plant part, growing conditions and harvest, so a whole-herb weight says little about active content.
Water extractHot water extraction concentrated and dried, which favours the more water-soluble glycosides and leaves much of the lipophilic fraction behind.Fits Formulas following the traditional decoction method and avoiding organic solvents entirely.Trade-off Water extracts the glycosides preferentially and yields a lower icariin concentration per gram than an alcoholic extract of the same herb.
Epimedium extract, icariin standardisedAqueous ethanol percolation concentrated and assayed by HPLC to a declared icariin percentage, commonly expressed as a stated percent of the dry extract.Fits Capsules and tablets that need a fixed, checkable active declaration per unit.Trade-off Standardising to one marker says nothing about the epimedin A, B and C content that accompanies it, and residual ethanol must be held to specification.
High-icariin extractA further purified fraction in which icariin is concentrated well above its natural proportion by chromatographic or crystallisation steps.Fits Products built around a single characterised molecule with a defined analytical method.Trade-off Enrichment removes the other prenylflavonoids present in the herb, so the material behaves as a single-compound ingredient rather than as a botanical extract.
Enzymatically converted aglyconeIcariin treated with beta-glucosidase enzymes before formulation, removing the sugar groups so the aglycone is supplied directly rather than relying on gut microbial conversion.Fits Formulas that want to reduce dependence on the user's own microbial deglycosylation capacity.Trade-off The aglycone is far less water soluble than the glycoside, so it needs a solubilising vehicle, and it costs more because of the added enzymatic conversion step.
What the strongest studies found

The essence, in one line each.

  1. Foliar application of mineral elements changed the accumulation of flavonoids, including the icariin-type prenylflavonoids, in the plants studied; this concerns raw material composition, not any effect in a person.In vitro study. Yang et al., 2023 (Metabolites). PMID 36837913

These are the studies our verdict leans on, chosen from the 1 we read for Epimedium Sagittatum. The full linked list is below.

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.